Lv3
340 积分 2025-01-23 加入
Teprotumumab for patients with active thyroid eye disease: a pooled data analysis, subgroup analyses, and off-treatment follow-up results from two randomised, double-masked, placebo-controlled, multicentre trials
1个月前
已完结
Teprotumumab for the Treatment of Active Thyroid Eye Disease
1个月前
已完结
Teprotumumab, an IGF-1R Blocking Monoclonal Antibody Inhibits TSH and IGF-1 Action in Fibrocytes
1个月前
已完结
The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy
1个月前
已完结
Long-term therapeutic effects of mesenchymal stem cells compared to dexamethasone on recurrent experimental autoimmune uveitis of rats
1个月前
已完结
Comprehensive characterization of pre- and post-treatment samples of breast cancer reveal potential mechanisms of chemotherapy resistance
1个月前
已完结
Presence of Tertiary Lymphoid Structures and Exhausted Tissue-Resident T Cells Determines Clinical Response to PD-1 Blockade in Renal Cell Carcinoma
1个月前
已完结
Intraperitoneal Infusion of Mesenchymal Stem/Stromal Cells Prevents Experimental Autoimmune Uveitis in Mice
2个月前
已完结
Uveitis: Molecular Pathogenesis and Emerging Therapies
2个月前
已完结
Ocular immune privilege in action: The living eye imposes unique regulatory and anergic gene signatures on uveitogenic T cells
2个月前
已完结
皖公网安备34019202002308
